About Accucaps
Accucaps is a company based in Windsor (Canada) founded in 1989 was acquired by Catalent in November 2016. Accucaps offers products and services including RP Scherer Softgel, Vegicaps® Capsules, EasyBurst® Chewable Softgels, and CosmoPod® Capsules. Accucaps operates in a competitive market with competitors including Unither, Akums, Recipharm, Jubilant Life Sciences and CoreRx, among others.
- Headquarter Windsor, Canada
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Catalent, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Accucaps
Accucaps offers a comprehensive portfolio of products and services, including RP Scherer Softgel, Vegicaps® Capsules, EasyBurst® Chewable Softgels, and CosmoPod® Capsules.
Advanced softgel technology for improved bioavailability in consumer health.
Plant-based encapsulation for nutritional and beauty supplements.
Chewable forms for enhanced taste and ease in supplement delivery.
Unit-dose capsules for targeted beauty and health formulations.
Funding Insights of Accucaps
Detailed funding history for Accucaps
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Accucaps
Accucaps has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Catalent.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CDMO offering drug and biologics development services
|
Locked | Locked | Locked |
Investor details for Accucaps
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Accucaps
Investment portfolio details for Accucaps
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Accucaps
Detailed financials for Accucaps
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Accucaps Comparisons
Peer comparison for Accucaps
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Accucaps
Accucaps operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Recipharm, Jubilant Life Sciences and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
|
| Locked | Locked | Locked |
Biopharma regulatory affairs, quality control, and strategy services are provided.
|
Detailed competitors of Accucaps
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Accucaps
Complete news archive for Accucaps
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Accucaps
Accucaps was founded in 1989.
Accucaps is headquartered in Windsor, Canada. It is registered at Windsor, Ontario, Canada.
Accucaps was founded in 1989 in Windsor, Canada, and operates as a contract development and manufacturing organization in the pharmaceutical sector. Focus is placed on soft-gel based oral drug delivery formulations, including proprietary multiphase products such as tablets in capsules and liquids in capsules. Facilities are inspected regularly by the US FDA and Health Canada. Packaging solutions, including pack development and child-resistant testing, are also provided.
Accucaps's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Accucaps offers RP Scherer Softgel, Vegicaps® Capsules, EasyBurst® Chewable Softgels, and CosmoPod® Capsules.
Accucaps has 1 investor. Key investors include Catalent.